5Downs R W. Comparative efficacy in the treatment of osteoporosis in postmenopausal women: alendonate vs calcitonin nasal spray[J]. J Clin Endocrinol Metab, 2000,85:1783 - 1788.
6Rosen C J, Kessenich C R. Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone disease[ J]. Drugs,1996,51(4) :537.
7Jeal W, Barrudeu L B, Metavish D. Alendronate: a review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis[J]. Drugs, 1997, 53(3):415.
10Kuljanin J,Jankovic I,Nedeljkovic J,et al.Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions[J].J Pharm Biomed Anal,2002,28(6):1215